Select Medical Holdings CORP Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Select Medical Holdings Corp. reports a director's completion of a merger transaction, converting common stock into cash consideration.
NYSE
Katherine R. Davisson, a Director at Select Medical Holdings Corp., reported a transaction related to the company's merger, converting shares into cash consideration.
NYSE
William H. Frist reported a disposition of Select Medical Holdings Corp. common stock following a merger agreement, converting shares into cash consideration.
NYSE
Marilyn B. Tavenner, a Director at Select Medical Holdings Corp., has reported the conversion of her common stock into cash following the company's merger.
NYSE
Select Medical Holdings Corp. Director Thomas Daniel reports on the conversion of his common stock into cash consideration following a merger agreement.
NYSE
Parvinderjit S. Khanuja reports a transaction related to the merger of Select Medical Holdings Corp, converting shares to cash consideration.
NYSE
James S. Ely III, a Director at Select Medical Holdings Corp, reported the conversion of his common stock into cash consideration as part of a merger agreement.
NYSE
John F. Duggan, Executive Vice President of Select Medical Holdings Corp., reported a disposition of 194,710 common shares on June 30, 2026, related to a merger agreement.
NYSE
Select Medical Holdings Corp. executive John Tyler Hollenbach reports a disposition of 135,084 common shares following a merger agreement.
NYSE
David S. Chernow, Vice Chairman of Select Medical Holdings Corp., reported transactions involving the disposition of company stock related to a merger agreement.
NYSE
Select Medical Holdings Corp. Senior Vice President Christopher Weigl reports transactions related to the company's merger, including share exchanges and cash conversion.
NYSE
Michael F. Malatesta, CFO of Select Medical Holdings Corp., reported transactions related to the company's merger agreement, exchanging shares for interests in the acquiring entity.
NYSE
Brian R. Rusignuolo, Executive Vice President at Select Medical Holdings Corp, has reported a disposition of common stock related to a merger agreement.
NYSE
Thomas P. Mullin, CEO of Select Medical Corporation, has filed a Form 4 detailing the disposition of securities in connection with the company's merger.
NYSE
John A. Saich, President of Select Medical Holdings Corp, reported a disposition of 736,412 common shares on June 30, 2026, related to a merger agreement.
NYSE
Martin F. Jackson, Executive Vice President of Select Medical Holdings Corp, reports changes in beneficial ownership of company stock following a merger agreement.
NYSE
Robert A. Ortenzio reports significant changes in beneficial ownership of Select Medical Holdings Corp. common stock, primarily related to a merger agreement.
NYSE
Russell L. Carson reports a disposition of 610,035 common shares of Select Medical Holdings Corp. as part of a merger transaction.
NYSE
Robert G. Breighner Jr. reports changes in beneficial ownership of Select Medical Holdings Corp. common stock related to a merger transaction.
NYSE
Robert G. Breighner Jr., Senior Vice President at Select Medical Holdings Corp., reported a transaction involving the surrender of 1,330 shares to cover tax withholding obligations.
NYSE
David S. Chernow, Vice Chairman of Select Medical Holdings, disposed of 22,586 shares to satisfy tax obligations related to restricted stock vesting.
NYSE
William H. Frist acquired 1,094 shares of Select Medical Holdings Corp. common stock on April 28, 2026, valued at $16.45 per share, as part of his director compensation.
NYSE
Director William H. Frist acquired 1,109 shares of Select Medical Holdings Corp common stock as part of his compensation.
NYSE
SELECT MEDICAL HOLDINGS CORP Executive Vice President John F. Duggan disposed of 4,865 shares of common stock to cover tax withholding obligations related to restricted stock vesting.
NYSE
Select Medical Holdings CFO Michael F. Malatesta disposed of 7,357 shares of common stock to cover tax withholding obligations related to restricted stock vesting.
NYSE
John F. Duggan, Executive Vice President of Select Medical Holdings Corp., was granted 50,000 shares of restricted common stock, vesting in 2029.
NYSE
Select Medical Holdings Director William H. Frist acquired 1,266 shares of common stock as part of his quarterly retainer.
NYSE
Select Medical Holdings Corp. granted 20,000 shares of restricted common stock to Chief Accounting Officer Christopher Weigl, vesting in 2029.
NYSE
Select Medical Holdings Corp. Executive Vice President John A. Saich reported a disposition of shares to cover tax obligations related to restricted stock vesting.
NYSE
Select Medical Holdings Corp. Co-President Thomas P. Mullin disposed of 22,045 shares of common stock to cover tax withholding obligations related to restricted stock vesting.